People are overdosing on the compounded versions of semaglutide drugs like Ozempic and Wegovy, the U.S. Food and Drug Administration said Friday. The two FDA-approved semaglutide injection products ...
Shares of Hims & Hers tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own compounded version of Novo Nordisk’s Wegovy oral weight-loss drug. After the ...
The US Food and Drug Administration (FDA) last week warned that differences in how drugmakers and compounders label the strength of injectable drugs may lead to dangerous dosing errors. "Conventional ...
Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. The ...
Direct-to-consumer virtual care company Hims & Hers is the latest digital health company to announce it will add GLP-1 medications to its offerings to assist users with weight-loss management. The San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results